104 related articles for article (PubMed ID: 35841843)
41. Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.
Shen W; Sakamoto N; Yang L
BMC Cancer; 2016 Jul; 16():413. PubMed ID: 27389173
[TBL] [Abstract][Full Text] [Related]
42. 21-gene recurrence score testing utilization among older women from different races: A population-based study.
Gulbahce HE; White S; Herget KA; Stoddard G; Camp NJ; Buys SS; Sweeney C
J Geriatr Oncol; 2021 Mar; 12(2):206-211. PubMed ID: 32646620
[TBL] [Abstract][Full Text] [Related]
43. The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis.
Kim HJ; Kim S; Freedman RA; Partridge AH
Breast; 2022 Feb; 61():77-83. PubMed ID: 34923225
[TBL] [Abstract][Full Text] [Related]
44. Effect of large tumor size on cancer-specific mortality in node-negative breast cancer.
Yu KD; Jiang YZ; Chen S; Cao ZG; Wu J; Shen ZZ; Shao ZM
Mayo Clin Proc; 2012 Dec; 87(12):1171-80. PubMed ID: 23218085
[TBL] [Abstract][Full Text] [Related]
45. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
Nagar H; Yan W; Christos P; Chao KSC; Nori D; Ravi A
Am J Clin Oncol; 2017 Jun; 40(3):300-305. PubMed ID: 25333731
[TBL] [Abstract][Full Text] [Related]
46. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
[TBL] [Abstract][Full Text] [Related]
47. Breast carcinoma in situ: An observational study of tumor subtype, treatment and outcomes.
Wu Q; Li J; Sun S; Zhu S; Chen C; Wu J; Liu Q; Wei W; Sun S
Oncotarget; 2017 Jan; 8(2):2361-2371. PubMed ID: 27926499
[TBL] [Abstract][Full Text] [Related]
48. Age at diagnosis in relation to survival following breast cancer: a cohort study.
Brandt J; Garne JP; Tengrup I; Manjer J
World J Surg Oncol; 2015 Feb; 13():33. PubMed ID: 25889186
[TBL] [Abstract][Full Text] [Related]
49. Competing-Risks Model for Predicting the Postoperative Prognosis of Patients with Papillary Thyroid Adenocarcinoma Based on The Surveillance, Epidemiology, and End Results (SEER) Database.
Bian F; Li C; Han D; Xu F; Lyu J
Med Sci Monit; 2020 Jul; 26():e924045. PubMed ID: 32710734
[TBL] [Abstract][Full Text] [Related]
50. Exploration of prognostic factors and the value of adjuvant chemotherapy in T1a,bN0M0 triple-negative breast cancer: a prospective cohort study based on the SEER database.
Wu J; Lv M; Yuan P; Ma Y; Tian P; Li L; Wang C; Lu Z; Yan M; Chen X; Liu Z
Gland Surg; 2022 Aug; 11(8):1341-1355. PubMed ID: 36082084
[TBL] [Abstract][Full Text] [Related]
51. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
52. Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium.
Mir MC; Marchioni M; Zargar H; Zargar-Shoshtari K; Fairey AS; Mertens LS; Dinney CP; Krabbe LM; Cookson MS; Jacobsen NE; Griffin J; Montgomery JS; Vasdev N; Yu EY; Xylinas E; McGrath JS; Kassouf W; Dall'Era MA; Sridhar SS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Daneshmand D; Black PC
Eur Urol Focus; 2021 Nov; 7(6):1347-1354. PubMed ID: 32771446
[TBL] [Abstract][Full Text] [Related]
53. Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype.
Wu Q; Li J; Zhu S; Wu J; Li X; Liu Q; Wei W; Sun S
Oncotarget; 2016 Dec; 7(52):87532-87542. PubMed ID: 27655704
[TBL] [Abstract][Full Text] [Related]
54. A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy.
Giannakeas V; Narod SA
Breast Cancer Res Treat; 2019 Oct; 177(3):691-703. PubMed ID: 31264063
[TBL] [Abstract][Full Text] [Related]
55. Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database.
Jung J; Hwang KT; Choi IS; Kim BH; Oh S; Kim J; Park JH; Park JH; Paek SH; Jeon SY; Yeo TH
Breast Cancer; 2022 Sep; 29(5):889-898. PubMed ID: 35616777
[TBL] [Abstract][Full Text] [Related]
56. Ten-year survival in women with primary stage IV breast cancer.
Eng LG; Dawood S; Sopik V; Haaland B; Tan PS; Bhoo-Pathy N; Warner E; Iqbal J; Narod SA; Dent R
Breast Cancer Res Treat; 2016 Nov; 160(1):145-152. PubMed ID: 27628191
[TBL] [Abstract][Full Text] [Related]
57. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
58. Initial Surgery and Survival in Stage IV Breast Cancer in the United States, 1988-2011.
Thomas A; Khan SA; Chrischilles EA; Schroeder MC
JAMA Surg; 2016 May; 151(5):424-31. PubMed ID: 26629881
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
60. Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Feb; 168(1):269-275. PubMed ID: 29143220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
